
Pharmagen, Inc. (PHRX)
PHRX Stock Price Chart
Explore Pharmagen, Inc. interactive price chart. Choose custom timeframes to analyze PHRX price movements and trends.
PHRX Company Profile
Discover essential business fundamentals and corporate details for Pharmagen, Inc. (PHRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
8 Mar 2012
Employees
24.00
Website
https://www.pharmageninc.comCEO
Mackie A. Barch
Description
Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes. The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin. In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs. The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013. Pharmagen, Inc. is based in Silver Spring, Maryland.
PHRX Financial Timeline
Browse a chronological timeline of Pharmagen, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PHRX Stock Performance
Access detailed PHRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.